Board Meeting3 Aug 2026, 05:31 pm
Amerise Biosciences Ltd Declares Un-audited Q2 FY27 Results
AI Summary
Amerise Biosciences Ltd announced that its Board of Directors has approved the un-audited standalone financial results for the quarter ended June 30, 2026. The board meeting took place on August 3, 2026. The financial results were reviewed by the Audit Committee and approved by the Board. The Statutory Auditors have carried out a limited review. The company operates in a single segment.
Key Highlights
- Board approved un-audited standalone financial results.
- Results are for the quarter ended June 30, 2026.
- Audit Committee reviewed the results.
- Statutory Auditors performed a limited review.
- Company has a single business segment.
Price Impact
More from AMERISE